Skip to main content
Publicerad: 2019-06-04 14:36 | Uppdaterad: 2019-06-05 09:27

Aktuella utlysningar, vecka 22-23, 2019

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska utlysningar

Call for proposals of research and development projects in medical technology - Barncancerfonden

The Swedish Childhood Cancer Foundation invites proposals for its call for research and development projects in medical technology. This supports basic research, development and clinical adaption projects, which highlight and solve research problems related to medical engineering for children with cancer. Research fields include, but are not limited to, irradiation technology, orthopedical implants, minimal invasive surgery, aids for people with disabilities, adjustment of analysis techniques, IT support, and disposable items. This also includes adapted design of existing products in order to facilitate medical treatment of children. Applications in the intersection between medical engineering and biotechnology may also be considered. Applications are invited from consortia consisting of at least one clinician and one researcher within technology. The grant is to be administered by a Nordic hospital, university or other HEI, or other Nordic organisation with research as its main purpose in collaboration with a hospital, university or other HEI. The total budget is SEK 12 million. Grants cover up to 25 percent of salaries of main and co-applicant for one to three years.

Closing date: 27 August 2019

Call for proposals of research and development projects in medical technology - Barncancerfonden

Call for proposals for development or innovation projects in the area of medical technology innovation for children with cancer - Barncancerfonden

The Swedish Childhood Cancer Foundation and MedTech4Health invite applications for their call for proposals for development or innovation projects in the area of medical technology innovation for children with cancer. This aims to generate products or services that contribute to an improved health care for children with cancer and their families. Projects may address development of new techniques for children with cancer or child-adapted design of existing products. Research fields include, but are not limited to, irradiation technology, orthopedical implants, minimal invasive surgery, aids for people with disabilities, adjustment of analysis techniques, IT support, and disposable items. Universities, hospitals, research institutes or other research-oriented organisations, as well as companies, may apply. The total budget is worth SEK 4.5 million.

Closing date: 27 August 2019

Call for proposals for development or innovation projects in the area of medical technology innovation for children with cancer - Barncancerfonden 

Forskningsmedel – Spädbarnsfonden

Spädbarnsfonden inbjuder ansökningar om forskningsmedel. Dessa stöder forskning som avser förhindra att barn dör före födelsen eller under spädbarnsperioden, samt för att förbättra bemötandet av drabbade föräldrar och närstående. Anslag kan sökas för biomedicinsk forskning inom fostermedicin och nyföddhetsvård, samt omvårdnads-, vårdvetenskaplig och psykosocial forskning. Disputerade forskare samt registrerade doktorander med handledarintyg kan söka. Forskningsprojekt som är helt eller delvis industrifinansierade är inte behöriga att söka.

Closing date: 31 August 2019

Forskningsmedel – Spädbarnsfonden 

Anslag för genetisk forskning – Erik Philip-Sörensens stiftelse för främjande av genetisk och humanistisk vetenskaplig forskning

Erik Philip-Sörensens stiftelse för främjande av genetisk och humanistisk vetenskaplig forskning inbjuder ansökningar om anslag för genetisk forskning. Detta stöder framtidsinriktad forskning inom ämnesområdet genetik. Stöd ges inte till rent klinisk eller medicinsk forskning. Forskare eller forskargrupper i Sverige kan söka. Ansökningar från yngre post-doc forskare som önskar att utveckla nya forskningsteman uppmuntras. Anslag ska administreras av svenskt universitet eller högskola.

Closing date: 19 September 2019

Anslag för genetisk forskning – Erik Philip-Sörensens stiftelse för främjande av genetisk och humanistisk vetenskaplig forskning

Teaching Sabbatical 2019 – STINT

By giving university researchers and lecturers who are passionate about education international experience, STINT wants to contribute to educational renewal of higher education in Sweden as well as the creation of new networks. STINT collaborates with selected universities and colleges in Asia and the US, where selected lecturers will reside throughout the autumn semester 2020. The intention is for the lecturer to teach, either by giving courses on one’s own, or through co-teaching. The nominee must hold a PhD, be employed by and well-established at a Swedish HEI. Great emphasis is put on the added value of the stay abroad, where experiences are expected to lead to change and positive dissemination impact at the Swedish university. Therefore, a nomination from the Swedish HEI is required.

Closing date: 19 September 2019

Teaching Sabbatical 2019 – STINT 

Europeiska utlysningar

Marie Skłodowska Curie Actions Individual Fellowships 2019

MSCA-IF are postdoc fellowships, for a project within Europe with a 2-year European Fellowship, or outside Europe (2 years) with a mandatory 1-year return phase to Europe with the 3-year Global Fellowship. Applicants are fellows with an identified PI and Host Organisation. The fellows should have a PhD degree or equivalent four years full-time research experience by the time of deadline 2019-09-11. Grants are typically up to €203,852 for two years for incoming fellowships to Sweden and used for salary and allowances for the fellow; research and overhead.

Closing date: 11 September 2019

Marie Skłodowska Curie Actions Individual Fellowships 2019

Call now open: ERC-2019-AdG advanced grants - Horizon 2020: Excellent Science, EU 

These support ground-breaking high-risk projects carried out by an established, leading principal investigator in any field of research. Applicants are expected to be active researchers who have a track-record of significant research achievements in the last 10 years and should be exceptional leaders in terms of originality and significance of their research contributions.

Approximately 166 grants are available, each worth up to €2.5m, over five years. An additional €1m may be requested.

Contact grantsoffice@ki.se if you’re interested in applying.

Closing date:  29 August 2019.

Call now open: ERC-2019-AdG advanced grants - Horizon 2020: Excellent Science, EU 

Early-career scientific development grant  - European Society for Paediatric Endocrinology, EUR

This supports early-career researchers gathering information and experience on a specific research issue or on a laboratory technique in the field of paediatric endocrinology. Support may be used to finance a short-term visit, lasting for up to six weeks, to an external research institution, or a visit of an outside expert in order to receive essential guidance, consultation or advice at the requester's home institute.

Members of the society and their collaborators may apply.

Four grants, worth up to €2,500 each are available.

Closing date: 31 July 2019, 31 October 2019, 31 January 2020, 30 April 2020, and repeated annually.

Early-career scientific development grant  - European Society for Paediatric Endocrinology, EUR 

Early-career research prize in vaccinology - International Union of Immunological Societies, DE 

The International Union of Immunological Sciences, in partnership with Vaccines Europe, invites nominations for its early-career research prize in vaccinology research and development. This recognises achievement in vaccine research and development in Europe, including the discovery of new vaccine antigens, new vaccines design, understanding the basics of the immune response, new technologies that will improve the future of vaccines and vaccination and that are supported by proof-of-concept data.

Associate professors and senior postdoctoral fellows may be nominated. They must be members of the IUIS, The European Federation of Immunological Sciences or any European immunology or vaccinology society.

The prize is worth €10,000 and paid travel, accommodation and meals to attend the European immunisation week.

Closing date: 31 July 2019 

Early-career research prize in vaccinology - International Union of Immunological Societies, DE  

Networking project grants - european Society for Paediatric Gastroenterology, Hepatology and Nutrition, EUR

These enable members to undertake research activities and network among centres at an international level. Activities may include interactive educational events and clinical networks. Proposals relevant to the society’s activities, such as the validation of guidelines, or clinical networks for testing treatment regimens or disease management, are encouraged.

Main applicants must be members of the society and all projects must include more than one country. Non-society members may participate in collaboration with society members. Collaboration between two or more society members in different centres is encouraged.

Three grants, worth up to €50,000 each, are available.

Closing date: 31 July 2019

Networking project grants - european Society for Paediatric Gastroenterology, Hepatology and Nutrition, EUR

Practical courses - European Molecular Biology Organisation, EUR 

Funding supports the organisation of courses to promote the transfer of new methods and emerging techniques in life science-related areas, and to enable participating students to implement novel techniques in their home laboratories. Practical courses are limited to between 20 and 25 participants, excluding speakers, who are usually early-stage postdoctoral researchers and advanced PhD students.

The maximum funding available for practical courses is €37,000. 

Deadline information: Organisers are encouraged to apply at least twelve months before the course takes place. Deadlines on 1 August 2019, 1 March 2020, and repeated annually

Practical courses - European Molecular Biology Organisation, EUR 

Amerikanska utlysningar

Federal Funding agencies

NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed): NIH

This Funding Opportunity Announcement (FOA) encourages applications that propose to complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The trials should be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high-priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (https://www.niaid.nih.gov/research/role).

Closing date: September 13, 2019; January 13, 2020; May 12, 2020; September 14, 2020 January 12, 2021; May 14, 2021; September 13, 2021; January 14, 2022; May 13, 2022, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-19-281

NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed): NIH

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional): NIH

This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying Substance Use Disorders (SUD), including fundamental brain function relevant to substance use.

Closing date: October 10, 2019; July 10, 2020; March 10, 2021; October 13, 2021; July 11, 2022; March 10, 2023, by 5:00 PM local time of applicant organization. 

Funding Opportunity Announcement (FOA): PAR-19-282

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional): NIH

PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional): NIH

NIDA is interested in research that addresses research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited. There is a need to better understand the effects of substance use on PrEP effectiveness and better inform PrEP implementation among substance users. More systematic data are needed regarding the impact of substance use on PrEP management and adherence, along with investigating potential unintended consequences of PrEP use that may be unique to substance users such as changes in harm reduction practices, as well as substance use as a contributor to health risk behaviors with consequences such as increased occurrence of STIs.

Closing date: October 10, 2019; July 10, 2020; March 10, 2021; October 13, 2021; July 11, 2022; March 10, 2023, by 5:00 PM local time of applicant organization. 

Funding Opportunity Announcement (FOA): RFA-DA-20-013

PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional): NIH 

Prostate Cancer Research Program (PCRP): DOD

The Fiscal Year 2019 (FY19) Defense Appropriation provides $100 million (M) to the Department of Defense Prostate Cancer Research Program (PCRP). The mission of the FY19 PCRP is to fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease. Within this context, the PCRP is interested in supporting research that addresses specific gaps in prostate cancer research and clinical care.

Therefore, applications are required to address one or more of the following FY19 PCRP Overarching Challenges:

• Improve the quality of life for survivors of prostate cancer

• Develop treatments that improve outcomes for men with lethal prostate cancer

• Reduce lethal prostate cancer in African Americans, Veterans, and other high-risk populations

• Define the biology of lethal prostate cancer to reduce death  

Closing date:
Idea Development Award (LOI: June 6, 2019 5:00 p.m. Eastern Time (ET), Full Application: September 19, 2019 11:59 p.m. ET);
Early Investigator Research Award (LOI: June 6, 2019 5:00 p.m. Eastern Time (ET), Full Application: June 27, 2019 11:59 p.m. ET);
Physician Research Award (LOI: June 6, 2019 5:00 p.m. Eastern Time (ET), Full Application: June 27, 2019 11:59 p.m. ET);

Clinical Trial Award (LOI: June 27, 2019 5:00 p.m. Eastern Time (ET), Full Application: July 18, 2019 11:59 p.m. ET);

Health Disparity Research Award (LOI: June 27, 2019 5:00 p.m. Eastern Time (ET), Full Application: July 18, 2019 11:59 p.m. ET);

Synergistic Population and Data Science Award (LOI: June 27, 2019 5:00 p.m. Eastern Time (ET), Full Application: July 18, 2019 11:59 p.m. ET);

Translational Science Award (LOI: June 27, 2019 5:00 p.m. Eastern Time (ET), Full Application: July 18, 2019 11:59 p.m. ET).

 

Funding Opportunity Announcement (FOA): Idea Development Award (W81XWH-19-PCRP-IDA); Early Investigator Research Award (W81XWH-19-PCRP-EIRA); Physician Research Award (W81XWH-19-PCRP-PRA); Clinical Trial Award (W81XWH-19-PCRP-CTA); Health Disparity Research Award (W81XWH-19-PCRP-HDRA); Synergistic Population and Data Science Award (W81XWH-19-PCRP-SPDSA); Translational Science Award (W81XWH-19-PCRP-TSA).

Prostate Cancer Research Program (PCRP): DOD 

Peer Reviewed Orthopaedic Research Program (PRORP): DOD

The Fiscal Year 2019 (FY19) Defense Appropriation provides $30 million (M) to the Department of Defense Peer Reviewed Orthopaedic Research Program (PRORP) to support the most significant gaps in care for the leading burden of injury and for facilitating return to duty by funding innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat and combat-related activities.  

Closing date:
Applied Research Award (ARA) (LOI: June 26, 2019 5:00 p.m. Eastern Time (ET), Full Application: September 18, 2019 11:59 p.m. ET);
Clinical Trial Award (LOI: June 26, 2019 5:00 p.m. Eastern Time (ET), Full Application: September 18, 2019 11:59 p.m. ET);
Clinical Translational Research Award (CTRA) (LOI: June 26, 2019 5:00 p.m. Eastern Time (ET), Full Application: September 18, 2019 11:59 p.m. ET).
 

Funding Opportunity Announcement (FOA): Applied Research Award (ARA) (W81XWH-19-PRORP-ARA); Clinical Trial Award (W81XWH-19-PRORP-CTA); Clinical Translational Research Award (CTRA) (W81XWH-19-PRORP-CTRA).

Peer Reviewed Orthopaedic Research Program (PRORP): DOD

DoD Melanoma Research Program (MRP): DOD

The FY19 Defense Appropriation provides $10 million (M) to the Department of Defense (DoD) Melanoma Research Program (MRP) to support innovative, high-impact melanoma research. The MRP challenges the research community to redefine the concept of prevention. Melanomagenesis is a multi-step process initiating from normal melanocytes to dysplasia through the development of melanoma and metastasis. A new paradigm of prevention may include stopping the initiation of dysplasia, halting the progress to malignancy, or blocking micro-metastases. The melanoma clinical, research, and patient community traditionally view prevention as the use of sunscreen/blockers to protect the melanocyte from harmful ultraviolet (UV) radiation. The MRP recognizes the usefulness of this strategy while tasking the research community to redefine prevention to include the entire melanomagenesis process.

Deadlines:
Idea Award (LOI: July 26, 2019 5:00 p.m. Eastern Time (ET), Full Application: October 23, 2019 11:59 p.m. ET);
Team Science Award (LOI: July 26, 2019 5:00 p.m. Eastern Time (ET), Full Application: October 23, 2019 11:59 p.m. ET);
Translational Research Award (LOI: July 26, 2019 5:00 p.m. Eastern Time (ET), Full Application: October 23, 2019 11:59 p.m. ET).
 

Funding Opportunity Announcement (FOA): Idea Award (W81XWH-19-MRP-IA); Team Science Award (W81XWH-19-MRP-TSA); Translational Research Award (W81XWH-19-MRP-TRA).

DoD Melanoma Research Program (MRP): DOD

Foundation

CAREER DEVELOPMENT PROGRAM, Leukemia & Lymphoma Society (LLS), USA

The Leukemia & Lymphoma Society (LLS) offers career development awards to postdoctoral fellows and instructors, as well as early-career independent investigators, engaging in basic, clinical, or translational research to help understand and treat hematologic malignancies and relevant premalignant condicitons. Please verify in our Guidelines & Instructions which award is appropriate for your level of experience and apply to that category of the award.

Deadlines: Eligibility due on September 1, 2019, 3:00 PM (Eastern Daylight Time); Abstract due on September 13, 2019, 3:00 PM (Eastern Daylight Time); Full application due on September 27, 2019, 3:00 PM (Eastern Daylight Time).

CAREER DEVELOPMENT PROGRAM, Leukemia & Lymphoma Society (LLS), USA

Call for Blepharospasm/Meige Research Proposals, Benign Essential Blepharospasm Research Foundation (BEBRF), US

Funds of up to $100,000 for one year are available for support of research directly related to the cause of, treatment for, and complications derived from treatments for benign essential blepharospasm or Meige's Syndrome, both forms of cranial dystonia. Proposals for improvement of existing treatments and for new treatments (such as medical marijuana and neuroplasticity training for blepharospasm) are welcome.

Closing date: August 31, 2019.

Call for Blepharospasm/Meige Research Proposals, Benign Essential Blepharospasm Research Foundation (BEBRF), US 

Research Grant, Mizutani Foundation for Glycoscience, Japan

The objective of the Foundation is to promote world-wide progress in glycoscience. In accordance with this objective, the Foundation provides research grants to outstanding proposals for basic and applied studies on glycoconjugate in the fields of organic chemistry, biochemistry, biophysics, molecular biology, cellular biology and medical sciences. The maximum amount of a grant is 7,000,000 yen (approximately US$58,000 as of March, 2019.) 

Closing date: September 1, 2019 (Tokyo Time).

Research Grant, Mizutani Foundation for Glycoscience, Japan